DCM
NGNE icon

Driehaus Capital Management’s Neurogene NGNE Stock Holding History

Driehaus Capital Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$661K Hold
32,765
– – ﹤0.01% 328
2025
Q4 		$675K Hold
32,765
– – ﹤0.01% 363
2025
Q3 		$568K Hold
32,765
– – ﹤0.01% 398
2025
Q2 		$490K Hold
32,765
– – ﹤0.01% 388
2025
Q1 		$384K Hold
32,765
– – ﹤0.01% 377
2024
Q4 		$749K Sell
32,765
-69,422
-68% -$2.58M 0.01% 340
2024
Q3 		$4.29M Hold
102,187
– – 0.04% 286
2024
Q2 		$3.72M Buy
102,187
+56,533
+124% +$1.99M 0.04% 272
2024
Q1 		$2.32M Buy
+45,654
New +$1.52M 0.02% 301
2019
Q4 		– Sell
-2,500
Closed -$143K – 549
2019
Q3 		$143K Buy
+2,500
New +$153K ﹤0.01% 477
2015
Q3 		– Sell
-8,215
Closed -$1.14M – 591
2015
Q2 		$1.14M Sell
8,215
-2,057
-20% -$313K 0.04% 404
2015
Q1 		$1.76M Sell
10,272
-2,195
-18% -$446K 0.06% 348
2014
Q4 		$1.87M Sell
12,467
-4,512
-27% -$643K 0.08% 323
2014
Q3 		$2.26M Buy
16,979
+372
+2% +$56.7K 0.09% 293
2014
Q2 		$3.11M Sell
16,607
-8,923
-35% -$1.72M 0.1% 275
2014
Q1 		$6.5M Buy
+25,530
New +$6.56M 0.2% 138

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Driehaus Capital Management's NGNE Position: Q1 2026 in Review

Driehaus Capital Management held its Neurogene (NGNE) position steady in Q1 2026 at 32,765 shares worth $661K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Driehaus Capital Management first reported a position in NGNE in Q1 2014 and has held it in 16 quarters since. The position peaked at $6.5M in Q1 2014. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Driehaus Capital Management held 32,765 shares of Neurogene worth $661K as of Q1 2026.
  • Driehaus Capital Management left its Neurogene share count unchanged in Q1 2026.
  • Neurogene made up ﹤0.01% of Driehaus Capital Management's portfolio in Q1 2026, its #328 holding.
  • Driehaus Capital Management first reported a position in Neurogene in Q1 2014 and has held it in 16 quarters since.
  • Driehaus Capital Management's Neurogene position peaked at $6.5M in Q1 2014.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.